CIK 0001528115 · Non-accelerated filer<br>Smaller reporting company
Annexon, Inc.
Sign in to watch- Ticker
- ANNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 275414423
- Phone
- (650) 822-5500
- Business address
- 1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200, BRISBANE, CA, 94005
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Open-market buy Director bought 4,115 shares at $3.17 ($13,045)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Open-market buy Director bought 4,115 shares at $3.05 ($12,551)
- 4 Open-market buy Director bought 4,115 shares at $2.09 ($8,600)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Open-market buy Director bought 4,115 shares at $2.43 ($9,999)
- 4 Open-market sale EVP & CHIEF INNOVATION OFFICER sold 1,116 shares at $2.58 ($2,879)
- 4 Open-market sale EVP & CHIEF FINANCIAL OFFICER sold 1,117 shares at $2.58 ($2,882)
- 4 Open-market sale EVP & CHIEF BUSINESS OFFICER sold 853 shares at $2.61 ($2,226)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
Page 5 of 27 · 524 filings